Sarepta Therapeutics Inc (LTS:0L35)
$ 121.67 0 (0%) Market Cap: 11.61 Bil Enterprise Value: 11.80 Bil PE Ratio: 78.90 PB Ratio: 9.50 GF Score: 82/100

Sarepta Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 04, 2020 / 01:00PM GMT
Release Date Price: $149.04 (-0.21%)
Operator

Good day, ladies and gentlemen, and welcome to the Sarepta Therapeutics 2020 Virtual Annual Meeting of Stockholders. As a reminder, today's program is being recorded. And now I'd like to introduce your host for today's program, Dr. Kathy Behrens, Chairwoman of Sarepta Therapeutics. Please go ahead.

M. Kathleen Behrens
Sarepta Therapeutics, Inc. - Independent Chairwoman

Good morning. Welcome to the 2020 Annual Meeting of Stockholders for Sarepta Therapeutics. It's now 9:00 a.m., and the meeting will please come to order. My name is Dr. M. Kathleen Behrens, and as Chairwoman of the Board of Directors of Sarepta, I will be presiding over this meeting. Doug Ingram, President and Chief Executive Officer of Sarepta, will also preside over portions of the meeting. Ty Howton, Executive Vice President, General Counsel and Corporate Secretary, will record the proceedings.

As all of you are aware, we are living in an extraordinary time. COVID-19 risk mitigation measures are keeping most of us in our homes and away from our typical daily routines. I hope that all

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot